Quest Pharmatech Inc V.QPT

Alternate Symbol(s): QPTFF

Healthcare Biotechnology

Quest PharmaTech Inc. is a Canada-based biopharmaceutical company. The Company is developing products to improve the quality of life. The Company is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The Company has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest’s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. It also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.

TSXV:QPT - Post by User

Quest Pharmatech Inc > Market is speaking

<< Previous

Bullboard Posts

Next >>

Post by PosNeg1on Apr 11, 2021 1:42pm

365 Views

Post# 32974528

Market is speaking

SP is speaking to value and confusion. Back to SP of years ago. QPT shareholders left holding paper money theoretically valued at 0.90. OncoThera Korea delisted. OncoQ private. PHIII trials ongoing, assume funding to complete in place. Until this paperwork resolved SP will lag or drop further.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario